Nigeria has announced an additional $346 million in domestic funding for 2026 to strengthen its health priorities, focusing on combating HIV and tuberculosis. The funding aims to enhance efficiency, accountability, and national ownership of health policies, supported by structural reforms such as the creation of the Multisectoral Accountability Framework for Tuberculosis (MAF-TB), which will improve monitoring of commitments and performance.
As part of its HIV prevention strategy, Nigeria has introduced lenacapavir, a twice-yearly injectable treatment, which is being rolled out free of charge in several states. The initiative targets high-risk populations and is designed to reinforce ongoing efforts to reduce new HIV infections across the country.
Health Minister Muhammad Pate emphasized that aligning resources across government levels and coordinating with partners is central to building an effective health system capable of ending TB and HIV. Nigeria continues to face significant public health challenges, with tuberculosis among the highest burdens globally and HIV/TB co-infection remaining a major concern.
The World Health Organization recommends expanding active case-finding, rapid testing, and ensuring uninterrupted access to both antiretroviral and tuberculosis treatments. Nigeria’s nationwide TB screening campaign, launched in 2023, detected more than 440,000 cases in 2025, a significant increase from 138,000 cases in 2020, with a treatment success rate reported at 94 percent.
